Home
Hope • Science • Life
We bring
hope to life
People facing life-threatening diseases need the possibility of tomorrow. We bring them hope through life-saving medicines.
We bring
hope to life
People facing life-threatening diseases need the possibility of tomorrow. We bring them hope through life-saving medicines.
Resources & Patient Stories
We aim to develop innovative, life-saving treatments and thereby bring hope to those facing life-altering conditions with no approved therapies.
Click here for Bipolar Depression Trial (NRX-101)
Resources & Patient Stories
We aim to develop innovative, life-saving treatments and thereby bring hope to those facing life-altering conditions with no approved therapies.
Click here for Bipolar Depression Trial (NRX-101)

NRX-101 – our drug in development for Bipolar Depression in patients with Acute and Subacute Suicidal Ideation & Behavior
Learn more about our clinical trial for severe bipolar depression with Sub-Acute Suicidal Ideation & Behavior (SSIB).
Highlights
As many as 50% of individuals with bipolar disorder attempt suicide or have serious thoughts of suicide and between 11-20% of those attempt and succumb to suicide.
Source:
Pallaskorpi, et al. “Incidence and predictors of suicide attempts in bipolar I and II disorders: A 5-year follow-up study,” Bipolar Disorders, 2016
“Suicide Attempts and Completions in Patients With Bipolar Disorder,” Psychiatric Times, 2007
Discovery Pipeline
We are advancing the development of the first oral investigational medicine to treat Bipolar Depression in Patients with ASIB and SSIB.
We are also exploring opportunities in other CNS disease areas such as Post-Traumatic Stress Disorder (PTSD).
We are also exploring opportunities in other CNS disease areas such as Post-Traumatic Stress Disorder (PTSD).
Each product in our pipeline has potential for additional indications beyond their initial target indications, and with this, we can save more lives and hope may become reality for even more people.